Future Price to Earnings: Telesis Bio, Inc. (TBIO)
Telesis Bio, Inc. (TBIO) generates revenue through the sale of automated DNA synthesizers and consumables, ensuring a steady cash flow. The shift in the company's forward P/E ratio on the GURU.Markets chart reflects market expectations, where the 0.00 mark indicates the valuation level. Meanwhile, the productivity of the BioXp platform development is being offset by pressure from major laboratory equipment market behemoths.
Financial and market metric breakdowns for Telesis Bio, Inc (TBIO)
- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
- balance sheet equity data:
- debt and liquidity details:
Total Debt to Equity Ratio Telesis Bio, Inc.|TBIO - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Telesis Bio, Inc.|TBIO - Company Debts|Debts to Book Capitalization Telesis Bio Inc.|TBIO - Long-Term Debt Volume|Company Short-Term Debt Telesis Bio|Quick Liquidity Indicator telesisbio.com
- earnings and market ratios statistics:
TBIO - Final Profit|Projected Future Earnings Telesis Bio, Inc.|TBIO - Business Payback Period|Future Price to Earnings Codex DNA|TBIO - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Telesis Bio Inc.|TBIO - Operating profit before deduction of amortization|Net earnings per share for the last 12 months Telesis Bio|TBIO - Net earnings per share for the last four quarters|Year-over-year net earnings per share growth for the last 12 months telesisbio.com|TBIO - Net earnings per one share growth for the current year|Earnings growth forecast for next year Telesis Bio, Inc.
General company analysis:Telesis Bio
For Telesis Bio, Inc. (TBIO), a developer of DNA and mRNA synthesis systems, the company's estimated forward P/E reflects market expectations for BioXp monetization amid the expansion of gene therapy. This indicator compares current market capitalization with expected annual net income, allowing a credit analyst to objectively assess the issuer's solvency and the risk of asset overvaluation before making an investment decision.
Main competitors
Forward P/E Multiple TEM|QGEN - Projected Price to Earnings Ratio|Future Price to Earnings Ionis Pharma IONS|Market Cap to Projected Earnings Repligen Inc. (RGEN)|Avidity Biosciences - Forward P/E Multiple|Market Cap to Projected Earnings crisprtx.com CRSP|GeneDx (WGS) - Future Price to Earnings|RARE - Market Cap to Projected Earnings|Projected Price to Earnings BEAM|SRPT: Future Price to Earnings Multiple|Forward P/E Multiple TWST|Future Price to Earnings TXG (10xgenomics.com)|Forward P/E Multiple NTLA (Intellia Therapeutics, Inc.)|Market Cap to Projected Earnings Stoke Therapeutics Inc (STOK)|BLFS - Future Price to Earnings|Projected Price to Earnings Ratio Wave Pharma|MAZE (Maze Therapeutics Inc) - Projected Price to Earnings|sionnatx.com - Future Price to Earnings Multiple|PRME (Prime Medicine) - Forward P/E Multiple|Taysha Gene Therapies Inc (TSHA) - Market Cap to Projected Earnings|Future Price to Earnings uniQure Corp (QURE)|MeiraGTx Corp - Price to Future Earnings Ratio|Forward P/E Multiple RGNX (REGENXBIO Inc.)|SLDB - Projected Price to Earnings|OCGN: Projected Price to Earnings|Market Cap to Projected Earnings Pacific Biosciences of California, Inc. PACB|BNTC (Benitec) - Projected Price to Earnings|DSGN: Market Cap to Future Earnings Ratio|RCKT (Rocket Pharmaceuticals) - Forward P/E Multiple|Future Price to Earnings FDMT|Forward P/E Multiple LXEO|Market Cap to Projected Earnings korrobio.com|Future Price to Earnings Editas EDIT|Silence Therapeutics Corp (SLN) - Projected Price to Earnings Ratio|ProQR Therapeutics NV - Forward P/E Multiple|CDXS (Codexis, Inc.) - Price to Future Earnings Ratio|Sangamo Therapeutics, Inc. (SGMO) - Future Price to Earnings|Price to Future Earnings Ratio NAUT|MGX (Metagenomi, Inc) - Forward P/E Multiple|Forward P/E Multiple Precision BioSciences Inc.|Projected Price to Earnings GBIO (Generation Bio Co.)|Market Cap to Future Earnings Ratio BOLD|Forward P/E Multiple XCUR (Exicure)|Imunon Inc (IMNN) - Projected Price to Earnings Ratio|PHIO - Future Price to Earnings|MBIO: Future Price to Earnings|RNAZ: Forward P/E Multiple|Projected Price to Earnings Ratio Bionano Genomics (BNGO)|Future Price to Earnings Applied DNA Sciences, Inc.|bluebird bio Inc. (BLUE) - Market Cap to Projected Earnings|Forward P/E Multiple IPA|Market Cap to Projected Earnings Omega Therapeutics Corp|Future Price to Earnings Singular Genomics Systems OMIC|Market Cap to Projected Earnings regulusrx.com (RGLS)|SYRS: Projected Price to Earnings|Future Price to Earnings Multiple TCON (TRACON Pharmaceuticals Inc.)|UBX: Forward P/E Multiple
